Search for dissertations about: "prognostic factors breast cancer"
Showing result 1 - 5 of 71 swedish dissertations containing the words prognostic factors breast cancer.
-
1. Molecular Cytogenetics in Sporadic Breast Cancer
Abstract : In recent time breast cancer has become the most common form of female cancer in the western world. It has been estimated that the lifetime risk of women falling ill from the disease is 10%. The number of patients diagnosed each year has been increasing steadily since the 1970s. READ MORE
-
2. Characterization of Male Breast Cancer : From Molecule to Clinical Outcome
Abstract : The aim of this thesis was to investigate different aspects of male breast cancer (MBC), and to compare these with findings in female breast cancer (FBC). In paper I, a population–based study was performed to investigate possible differences in treatment and outcome between MBC and FBC patients. READ MORE
-
3. Studies on Prediction of Axillary Lymph Node Status in Invasive Breast Cancer
Abstract : Breast cancer is the most common malignancy among females in Sweden. Axillary lymph-node dissection is a standard procedure in the management of breast cancer, aiming at obtaining prognostic information for adjuvant therapy decisions. Axillary dissection entails considerable morbidity. READ MORE
-
4. Predictive markers for tamoxifen response in primary breast cancer
Abstract : It is well-known that a majority of breast cancers are hormone-dependent, making endocrine therapy an important adjuvant treatment after surgery. Susceptibility to endocrine treatment is determined by the presence of estrogen receptors (ER) and progesterone receptors (PR) in the tumors. READ MORE
-
5. The impact of the progranulin-sortilin axis on breast cancer stem cell activity and patient outcome
Abstract : Breast cancer is the most common cancer in women worldwide. Still today, despite current breast cancer therapies, many patients experience treatment resistance and relapse, which are believed to be due to failure in targeting treatment-resistant cancer stem cells. READ MORE